Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Thanks for the info. Is NAV notifications different to end of year etc? If not the next NAV update won’t be available until 30 days from today!
If the company is not in their 'closed' period - the period either side of their revenue/profitability announcements then directors can buy and sell the company shares.
It would have to be proposed at a board meeting and be ratified, and the investor relations/compliance team would have to agree.
It a process but fairly straightforward.
Does anyone know if there is a a time period for directors not being able to purchase shares with the release of the NAV? I can’t find this on the web. Thanks in advance.
Technical's look mixed as MERI has broken out of it's trendline on October 15th on the downside. This is at odds with the sector and the few similar funds such as AUGM or sector like European technology or software. I wounder if much of the selling is automated as a result of these technicals. Perhaps the placing of 150p is linked.
MERI is a fund and it should recover with the sector. The overdue Facsheet will contain a NAV that we need to be a positive and I don't see why not given the sector progress.
I bought some more yesterday and I hold more MERI than any other fund. I think the technical risk will be over given a favorable NAV and any other drop or sideways movement should be ignored until we get this news.
Together with a large trade for MERI, the results for Starling are out.
https://www.yourmoney.com/saving-banking/starling-bank-breaks-even-and-says-itll-be-first-challenger-to-turn-profit/
Maybe I need to research more I don't know for sure. Generally in fast-growing private markets fundraising happen with great regularity and the result is a NAV ahead of the previous NAV + cash. Private equity valuations are typically only done properly every 12 months (during COVID they had been adjusted). So by the time of the placing the NAV of last year is out of date. Granted by December the amount will be reevaluated anyway, but since there is a massive growth in public companies I thought Grahpcore and Starling could be in a for a greater rise than expected.
Hi DireEmblem, In private equity and that of high growth companies fundraising is always done at a higher price than paid and the dilution effect here against the market cap (just under 2 billion) is minimal. The net effect is a rise in NAV. One example is to look at is TransferWise where the premium prices paid far exceeds that of the dilution.
British AI chip start-up Graphcore close to adding another $200 million in funding
https://www.computing.co.uk/news/4022936/british-ai-chip-start-graphcore-close-adding-usd200-million-funding
DireEmblem I emailed Jupiter/MERI but they simply said factsheets are updated quarterly and did not acknowledge the lateness.
Starling/Transferwise exposure is great but Graphcore is also doing another fundraising so that will add to the NAV. I believe the NAV is like a coiled spring and we have about 20% gain for Christmas. The US markets will rise and there will be a lag for us to buy more MERI from any profits here and the US will then help NAV reports. This is the best tech trust outside the US market
https://www.bloomberg.com/news/articles/2020-11-06/u-k-s-graphcore-said-to-raise-funds-at-over-2-billion-value
I presume MERI would be part of this...
https://techcrunch.com/2020/11/06/starling-fund-raising/
Half a million sold at 133p yesterday yet they want to charge me 139p to buy. That's not a fair price. Someone large must be accumulating for less than I can buy.
I have had time to take a look. It a mix of reasons. Some profit-taking. Some because Biden is bad for the UK. Some because listed private equity is often volatile at times of uncertainty. This is all factored in.
You have to ask why they are selling in relative size and therefore what is it they know?
Hundreds of thousands of pounds being sold off at now well under NAV at 133.00p and screaming a buy. I have topped up aa little closer to NAV.
Thanks Mr.Flibbles.
I know Baillie Gifford very well indeed. Dealt for them many times.
I will have a close look at GROW.
roleybirkin, thank you for the list. In return, I will give you GROW (NAV 555p) that is backed by Baillie Gifford buying in who are not traders.
Hi Mr Fibbles,
I have two sides to my portfolio.
I really like the slow burning long term funds especially those that invest in new ideas and technology like:-
- Merian
- Pires
- Riverfort and
- KR1
All great management teams and have a history of picking winners.
The second side is the more speculative with early holdings in:-
- Novacyt
- Hemogenyx
- Bidstack
- Open Orphan and
- Alien Metals
All have excellent opportunity in exciting sectors.
All bar Bids have good strong management teams and you have to buy management excellence.
Good luck.
Been lots of large sells this week that has dragged the share price well under the 148p. I would suspect that after this seller clears we will be over the placing price and confirmation of our stake in You & Mr Jones is the world's first global brandtech group. Followed by a NAV update and long-awaited update to the factsheet.
@roleybirkin, I am snooping around your history. Pires Investments gives me some interest. Thank you.
Great performance by a great team...
Very happy to be holding and expect the NAV to be significantly better at next valuation date.
Seneca IM continues to back Merian Chrysalis after latest fundraising 'turnaround'
https://www.investmentweek.co.uk/news/4021798/seneca-im-continues-merian-chrysalis-fundraising-turnaround
MERI's growth trend while not sustainable is still conservative amongst it's sector piers. The next quarterly NAV update will not be for some time but at the current rate everything is looking promising for more gains by the end of the year. I have added some more today at the placing price and hope the share price stays low before I can free up some funds by the end of the year.
£75 million raised at £1.50. This is great news and the share price should go upwards strongly after ll is said and done.
All coming in now, Klarna Holding AB follow-on investment.
https://www.lse.co.uk/rns/MERI/portfolio-update-qytkegn5umvjdqj.html
I would not be surprised if we get news from the other excellent companies in this portfolio... MERI is probably the best in Europe, I would say better potentially than HGCapital. Another similar company is GROW that is now trading under it's NAV of 555p.
Merian Chrysalis Investment Company said it had agreed to commit around £23m of follow-on capital to an investment in its portfolio. The details of this transaction, it said, currently remained confidential, with a further update to be made in due course. Merian Chrysalis said the funding round saw significant participation from new investors, as well as strong support from other existing holders. The transaction had been undertaken at a valuation representing a material mark up in the company's current carrying value of the asset. It was anticipated to lead to a gross increase in the company's last reported net asset value per share of about 4.4p, which was 137.26p as of 30 June.
https://www.sharesmagazine.co.uk/news/market/7079688/Merian-Chrysali-commits-pound23m-to-portfolio-invesment